Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
RAPT Therapeutics (RAPT)
NASDAQ:RAPT
RAPT Therapeutics (RAPT) Stock Price & Analysis
182 Followers
RAPT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.95 - $31.45
Previous Close$12.23
Volume361.62K
Average Volume (3M)311.75K
Market Cap
$420.20M
Enterprise Value$223.20M
Total Cash (Recent Filing)$205.00M
Total Debt (Recent Filing)$8.00M
Price to Earnings (P/E)-4.5
Beta1.28
Next Earnings
Nov 09, 2023EPS Estimate
-$0.75Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.70
Shares Outstanding34,358,152
10 Day Avg. Volume358,589
30 Day Avg. Volume311,746
Standard Deviation0.29
R-Squared0.00754
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)2.11
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit146.17
Enterprise Value/Ebitda-2.17
Forecast
1Y Price Target
$35.50Price Target Upside190.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
RAPT Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RAPT FAQ
What was RAPT Therapeutics’s price range in the past 12 months?
RAPT Therapeutics lowest stock price was $11.95 and its highest was $31.45 in the past 12 months.
What is RAPT Therapeutics’s market cap?
Currently, no data Available
When is RAPT Therapeutics’s upcoming earnings report date?
RAPT Therapeutics’s upcoming earnings report date is Nov 09, 2023 which is in 21 days.
How were RAPT Therapeutics’s earnings last quarter?
RAPT Therapeutics released its earnings results on Aug 11, 2023. The company reported -$0.66 earnings per share for the quarter, beating the consensus estimate of -$0.781 by $0.121.
Is RAPT Therapeutics overvalued?
According to Wall Street analysts RAPT Therapeutics’s price is currently Undervalued.
Does RAPT Therapeutics pay dividends?
RAPT Therapeutics does not currently pay dividends.
What is RAPT Therapeutics’s EPS estimate?
RAPT Therapeutics’s EPS estimate is -$0.75.
How many shares outstanding does RAPT Therapeutics have?
RAPT Therapeutics has 34,358,150 shares outstanding.
What happened to RAPT Therapeutics’s price movement after its last earnings report?
RAPT Therapeutics reported an EPS of -$0.66 in its last earnings report, beating expectations of -$0.781. Following the earnings report the stock price went down -2.798%.
Which hedge fund is a major shareholder of RAPT Therapeutics?
Among the largest hedge funds holding RAPT Therapeutics’s share is Perceptive Advisors LLC. It holds RAPT Therapeutics’s shares valued at 43M.
---
RAPT Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$35.50 (190.27% Upside)
$35.50 (190.27% Upside)
Blogger Sentiment
Bullish
RAPT Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Increased
By 46.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $5.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.63%
12-Months-Change
Fundamentals
Return on Equity
-49.15%
Trailing 12-Months
Asset Growth
-0.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
RAPT Therapeutics
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for patients in oncology and inflammatory diseases.. The company was founded in 2015 and is headquartered in South San Francisco, CA.
---
Top 5 ETFs holding RAPT
Vanguard Total Stock Market ETF
$19.96M
Vanguard Health Care ETF
$1.29M
Fidelity Nasdaq Composite Index ETF
$444.69K
Schwab U.S. Broad Market ETF
$167.06K
Vanguard Russell 3000 ETF
$28.64K
Up to five ETFs with an Outperform Smart Score that hold RAPT. The ETFs are listed according to market value of RAPT within the ETF
Aileron Therapeutics
―
PDS Biotechnology
―
Protagonist Therapeutics
―
Scholar Rock Holding
―
---